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Abstract
Background: To ascertain equity in financing for essential medicines and health supplies (EMHS) in Uganda, this
paper explores the relationships among government funding allocations for EMHS, patient load, and medicines
availability across facilities at different levels of care.
Methods: We collected data on EMHS allocations and availability of selected vital medicines from 43 purposively
sampled hospitals and the highest level health centers (HC IV), 44 randomly selected lower-level health facilities (HC
II, III), and from over 400 facility health information system records and National Medical Stores records. The data
were analyzed to determine allocations per patient within and across levels of care and the effects of allocations on
product availability.
Results: EMHS funding allocations per patient varied widely within facilities at the same level, and allocations per
patient between levels overlapped considerably. For example, HC IV allocations per patient ranged from US$0.25 to
US$2.14 (1:9 ratio of lowest to highest allocation), and over 75 % of HC IV facilities had the same or lower average
allocation per patient than HC III facilities. Overall, 43 % of all the facilities had optimal stock levels, 27 % were
understocked, and 30 % were overstocked. Using simulations, we reduced the ratio between the highest and
lowest allocations per patient within a level of care to less than two and eliminated the overlap in allocation per
patient between levels.
Conclusions: Inequity in EMHS allocation is demonstrated by the wide range of funding allocations per patient
and the corresponding disparities in medicines availability. We show that using patient load to calculate EMHS
allocations has the potential to improve equity significantly. However, more research in this area is urgently needed.
Trial registration: The article does not report any results of human participants. It is implemented in collaboration
with the Uganda’s Ministry of Health, Pharmacy Division.
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Background
For a health system to be equitable, essential health care
must be provided according to need [1–6]. Equity in
health care requires that the government health system
not only prevents and treats diseases, but ensures equit-
able access to health care products and services, that is,
vulnerable populations that need more get more [3–5].
The Government of Uganda’s national drug policy un-
derscores three important principles of quality of care,
equitable and efficient use of available resources, and ad-
equate availability of affordable EMHS at all times [7].
A facility’s EMHS needs will be a function of charac-
teristics that include level of care; number and skills of
health workers; types, quantity, and quality of services
provided; and population characteristics such as size,
disease burden, socioeconomic status, and health care-
seeking behavior (Fig. 1) [6]. The influence of these fac-
tors, and therefore the facilities’ EMHS requirements,
differ among facilities at the same level of care and be-
tween facilities at different levels of care. These product
requirements are a proxy for need, and the facility’s cap-
acity to meet this need will depend to a great extent on
its funding allocation.
Equity can be assessed in two ways: horizontally and
vertically [8]. We define horizontal equity to mean that
patients with same needs receive the same treatment
and vertical equity to mean that patients with greater
needs receive more health care than those with lesser
needs. Although influenced by the health system’s refer-
ral structure and peoples’ care-seeking behavior, gener-
ally, patients with more health care needs should be
treated at higher-level facilities that can provide increas-
ingly specialized treatments.
Existing information on facility EHMS allocations and
patient loads in Uganda points to large differences in the
ability of facilities within the same level of care to re-
spond to patient needs and ensure EMHS availability.
However, no systematic studies have investigated or doc-
umented equity in Uganda’s EMHS funding allocations.
Uganda’s population in 2012/13 was about 35.4 million
with a growth rate of 3.2 % per year [9]. Life expectancy
in Uganda is 54.5 years; mean number of years of
schooling is 4.7, and per capita income is US$497 [10].
Poverty levels are higher in rural rather than in urban
areas and the worst in the northern part of the country.
Communicable diseases are the leading cause of morbid-
ity, with malaria accounting for 37 % of all outpatient
visits in 2012/13 [11]. The primary causes of mortality in
children are malaria (28 %) pneumonia (15 %), and
anemia (10 %) [12].
Administratively, Uganda is divided into 112 districts,
which are further divided into counties, sub-counties,
and parishes. In 2013, the country had 5,229 health facil-
ities, of which 55 % were government-owned, 17 % were
private not-for-profit, and 28 % private for-profit [13].
The public health system structure includes national re-
ferral hospitals, regional referral hospitals, general or
district hospitals, health centers (HC) IV, HC III, HC II,
and village health teams (HC I). HC I to HC IV services
are categorized as primary care. General hospitals and
the health centers report to district governments, while
the referral hospitals are under central government over-
sight [5]. The referral system is not well implemented in
Uganda, and people commonly seek care at higher level
facilities first, where the treatment cost per patient is
much greater compared with comparable treatment pro-
vided at lower-level facilities.
Most Ugandans seek health care in the public sector
resulting in caseloads that are almost five times those of
private for-profit providers—10.0 outpatients per pro-
vider per day compared with 2.2 for private providers. In
addition, the caseloads of public sector rural practi-
tioners are more than twice those in urban areas [14].
One of the key challenges is insufficient human re-
sources, with up to 37 % of health worker posts in the
public sector going unfilled [11].
Every year, Uganda’s Parliament allocates funding to
procure EMHS through a budget vote. The Ministry
of Health negotiates with the Ministry of Finance on
the annual budget. The National Medical Stores, the
parastatal organization responsible for procurement,
storage, and distribution of EMHS to government
health facilities, is responsible for carrying out
resource allocation decisions. The Government of
Uganda funds EMHS through Vote 116, which is an
Fig. 1 Factors influencing EMHS need in a health facility. Population,
morbidity levels, poverty, perceptions about quality of care,
availability of medicines and health workers all influence the number
of patients visiting a health facility, and as such, the facility’s
EMHS needs
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account that the Ministry of Health established at the
National Medical Stores to ensure effective and effi-
cient use of funds. Vote 116 is managed so that re-
sources are allocated to a number of vote outputs,
including medicines for different purposes. For ex-
ample, in 2013/14, Vote 116 funds were allocated as
follows: 45 % went to medicines and commodities for
tuberculosis, malaria, and HIV/AIDS; 16 % for
medicines used at specialized institutes as well as re-
productive health commodities and emergency medi-
cines; and the remaining 39 % for EMHS used at HC
II-IV and general and referral hospitals. In 2013/14,
funds for EMHS (excluding HIV/AIDS, malaria, and
tuberculosis products) amounted to US$0.99 per
capita [15].
This study focuses on the equity of Vote 116 alloca-
tions to health facilities for EMHS. The National Med-
ical Stores has the authority to suggest changes to the
prescribed allocation of resources at the start of each fi-
nancial year, but the decision rests with the Ministries of
Health and Finance. Public sector facilities receive an
annual EMHS allocation as a budget line to draw upon.
All facilities at one level, such as HC IVs, receive the
same EMHS allocations, and EMHS allocations increase
with each level of care. There are three EMHS allocation
bands for regional referral hospitals. The vote 116 allo-
cation is the only funding for EMHS available to the
health facilities as there are no cost recovery mecha-
nisms in place and the EMHS are provided free of
charge to the patients.
EMHS supply to higher-level facilities (HC IVs and
hospitals) is organized as a “pull” or order-based sys-
tem, while lower-level facilities (HC II and III) have a
“push” or kit-based system. In the pull system, facil-
ities prepare EMHS orders every other month on the
basis of their needs and on the available EMHS allo-
cation in the budget line at the National Medical
Stores. HC II and HC III facilities receive pre-packed
EMHS kits equivalent to the value of their EMHS
allocation every other month—one kit for HC IIs and
a larger, more diversified kit for HCIIIs. The HC III
kit is more than double that of the HC II kit, both in
the quantity of medicines and supplies and in value.
In the past, Uganda’s pharmaceutical supply system
has varied from entirely order-based to having
combinations of pull and push systems. A pull system
is more cost-effective, but it requires considerable
stock management and quantification capacity within
the facilities; whereas, push distribution does not rely
on staff ability to quantify, order, or track their ex-
penditures. After EMHS availability became a chronic
problem, the government re-introduced the current




This paper examines equity of EMHS funding alloca-
tions by exploring the relationships between EMHS allo-
cation, patient load, and EMHS availability.
Design
The study is cross-sectional descriptive study based on
analysis of questionnaires, survey reports and health re-
cords from government health facilities, Ministry of
Health and National Medical Stores in Uganda.
Data collection
To explore equity in EMHS allocation at all levels of
care, we used three data collection approaches. First, we
obtained information on facility EMHS allocation, pa-
tient load (number of visits), and medicines availability
from order-based facilities (HC IVs and hospitals)
through a questionnaire. Second, we gathered informa-
tion on EMHS allocation and medicines availability from
surveys of kit-based facilities (HCIIs and HC IIIs) in
2012/13 [8]. Third, we collected EMHS allocation infor-
mation from the National Medical Stores for all facilities
for financial year 2013/14 and used it to validate facility
data and to simulate more equitable funding allocation
options. Patient load information was obtained from the
national district health information system.
Questionnaire for order-based facilities
We purposively sampled 14 (100 %) regional referral
hospitals, 11 (23 %) general hospitals, and 16 (10 %) HC
IVs. Four inclusion criteria were used to select general
hospitals and HC IVs: health facilities had to 1) be lo-
cated in the 59 (53 %) districts that had a Supervision
Performance Assessment and Recognition Strategy
(SPARS) in place to build capacity in medicines manage-
ment; 2) have a SPARS supervisor on site, who could
collect data without additional training or travel ex-
penses; 3) be in the public sector and therefore allocated
a Vote 116 budget line for EMHS procurement at the
National Medical Stores; and 4) have a minimum per-
formance level in medicines management, as per the lat-
est SPARS performance assessment that measures 25
pharmaceutical system indicators [17].
The facilities’ measured performance had to score at
least 12.6 (maximum 25) with a stock management score
above 2 (maximum 5) to ensure that the findings would
not be biased by poor medicines management capacity.
Eleven general hospitals and 44 HC IVs met the inclu-
sion criteria. The 44 HC IVs were stratified based on
2012 annual patient numbers. Of the 37 HC IVs with
complete patient load datasets, we chose for the sample
eight facilities with the highest patient loads and eight
with the lowest to assure that we captured facilities with
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the highest and lowest EMHS allocations per patient.
We emailed a pre-tested questionnaire with closed and
open-ended questions to SPARS supervisors and re-
gional pharmacists to fill out using facility service statis-
tics for July 2012 to June 2013. Telephone and email
follow-up resulted in a 93 % response rate.
Kit survey from HCIII and HCII facilities
The Ministry of Health annual kit surveys in 2012 and
2013 assessed how well the EMHS kit supply system was
fulfilling the needs related to content and quantities deliv-
ered to HC IIs and HC IIIs randomly selected from 12
districts with equal regional representation. We used data
on availability and patient load from 22 HC IIs and 22 HC
IIIs from the 2012 kit survey [16]. Facility patient attend-
ance data for eight months were extrapolated to annual
estimates.
EMHS Vote 116 allocation data and patient attendance
data
To simulate alternative allocation options to improve
equity in health facilities, we used 2012/13 facility-based
inpatient plus outpatient attendance statistics from the
national district health information system and corre-
lated them with 2013/14 Vote 116 EMHS allocations
and 2012/13 EMHS allocations for the kits obtained
from the National Medical Stores. These data were used
to determine the range of allocations per patient at vari-
ous levels of care and to investigate what opportunities
exist to optimize the allocation per facility and increase
equity. Complete sets of allocation and patient data were
available for 400 (23 %) HC IIs, 174 (96 %) HC IVs, and
47 (72 %) general hospitals; therefore, we limited the
data simulation to these levels of care.
We calculated per patient allocations for HC IVs
and hospitals by multiplying the number of inpatient
visits by 3.3 and adding it to the number of
outpatients, based on estimates that the cost of
EMHS for inpatients is about 3.3 times the costs for
outpatients [18, 19].
Availability of EMHS
We collected information on the availability of a basket
of lifesaving, widely used medicines to treat high-
morbidity conditions (pneumonia and diarrhea) that take
up significant proportions of the EMHS budget.
(Table 1). Malaria, HIV/AIDS, and tuberculosis medi-
cines were excluded because they are not funded using
the EMHS allocation. For HC IIs, HC IIIs, and HC IVs
and general hospitals the basket included six, 10, and 14
medicines, respectively (Table 1).
Availability information included stock on hand on the
day of data collection, average monthly consumption,
and stock-out days in a 12-month period in 2012/13,
obtained from the stock cards and books.
Analysis
Using MS Excel, we analyzed the data to explore: 1)
horizontal equity using EMHS allocation per patient
within the same level of care; 2) vertical equity using
EMHS allocation per patient by level of care; 3) health
facility ability to meet needs within its EMHS allocation;
and 4) options for improving equity through alternative
allocation methods and principles.
Table 1 Baskets of vitala and lifesaving medicines used to investigate availability at different levels of care
Medicine Description HC II HC III HC IV and hospital
Amoxicillin 250 mg tablet ✓ ✓ ✓
Carbamazepine 200 mg N/A ✓ ✓
Ceftriaxone 1 g powder for injection N/A N/A ✓
Chloramphenicol 1 g injection N/A N/A ✓
Ciprofloxacin 500 mg tablet ✓ ✓ ✓
Cotrimoxazole 480 mg tablet ✓ ✓ ✓
Dextrose 5 % infusion N/A ✓ ✓
Insulin Mixtard human 100 IU/Ml N/A N/A ✓
Metronidazole 500 mg/100 ml infusion N/A N/A ✓
Oral rehydration salts ✓ ✓ ✓
Phenytoin 100 mg tablet N/A ✓ ✓
Sodium chloride 0.9 % infusion N/A ✓ ✓
Tetracycline eye ointment 1 % ✓ ✓ ✓
Zinc Sulfate 20 mg tablet ✓ ✓ ✓
aCategorized as vital in the EMHS list of Uganda 2012 and approved for use at the respective level of care for which it was investigated and all levels above. N/A:
medicine is not allowed for use at the level of care
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Horizontal equity assessment
Population and health system factors such as health be-
havior, demographics, geography, urbanization, epidemi-
ology, poverty, EMHS allocations, facility staffing and
density, among others will determine health facility pa-
tient loads, and as such, the facility’s EMHS needs
(Fig. 1). In this study, we used patient load as a proxy
for EMHS needs and the EMHS allocation per patient
within each level of care as a proxy of horizontal equity,
recognizing that patients’ needs vary within the same
level of care. The EHMS allocation per patient was de-
termined by dividing the annual facility EMHS allocation
by the actual annual patient loads (in HC IVs and hospi-
tals) or by extrapolated patient loads (in HC IIs and
IIIs).
Vertical equity assessment
The cost of treating a patient should increase with each
level of care because of the greater breadth and depth of
services at higher levels. We limited our assessment of
vertical equity to a comparison of the EMHS allocations
per patient between levels of care. Assessing the ideal al-
location per patient relative to the requirements at each
level of care was beyond the scope of this study.
Assessment of ability to meet facility needs within the
EMHS allocation
A health facility’s ability to meet its patients’ EMHS
needs is closely linked to EMHS availability and is a
function of its EHMS allocation. To calculate the
months of stock on hand, we divided the availability re-
corded on the day of the study for each basket item by
its average monthly consumption. An item was optimally
stocked if the facility had two to five months’ worth of
stock on hand, understocked if it had less than two
months’, and overstocked if it had more than five
months’ worth of stock. For each facility, we calculated
the percentage of items in each category of 1) optimally
stocked, 2) overstocked, and 3) understocked. Then we
calculated the average percentage for each of the three
categories for each level of care based on the individual
category scores for all facilities within the level of care.
The number of stock-out days in a year (actual or ex-
trapolated) was divided by 365 for each product in the
basket and aggregated to calculate the facility’s percent-
age of time out of stock. To assess the ability of a facility
to fulfill its EMHS needs, EMHS allocations and per pa-
tient allocation were correlated with the average percent
availability.
Assessment of options to improving equity through
alternative allocation
We carried out simulations to determine the EMHS al-
locations needed for each facility to ensure a ratio of less
than two between the highest and lowest allocation per
patient in a facility at a specific level of care. We created
patient load ranges or bands within each level of care,
for example, five bands for HC IVs and general hospitals.
Based on the total EMHS allocation available for the
level of care, we proposed an average allocation to each
facility within that band. Then, based on each facility’s
actual patient load, the allocation per patient was calcu-
lated. We listed the highest and lowest per patient allo-
cation for each proposed band and compared their
ratios to ensure that they were less than two.
Ethical approval
Not applicable, no approval is required. The study does
not involve human participants, human data, human tis-
sue or animals. Data collection was done by SPARS su-
pervisors and regional pharmacist who are Ministry of
Health staff and the data they collected did not include
any human subject related data. The data related to
medicines budgets, procurement expenditures of medi-
cines by the health facilities and patient load data aggre-
gated for each facility. Therefore no ethical approval or
waiver from an ethics committee was required.
Results
Patient loads for 2012/13 varied considerably between
facilities and by level of care, although generally they
were higher at higher levels of care. Regional referral
hospitals’ annual patient loads ranged from 75,735 to
343,266; general hospitals from 60,508 to 154,766; HC
IVs from 7,900 to 67,000; HC IIIs from 7,426 and
20,572, and HC IIs between 5,266 and 16,689.
Horizontal equity
Our study documented wide variations in EMHS alloca-
tions per patient within the same levels of care. HC IVs
and regional referral hospitals had the widest disparities
in patient load and therefore in allocation per patient
(Fig. 2 and Table 2). At HC IVs, the allocations per
Fig. 2 Box-plot depicting EMHS allocation per patient in 2012/13 by
level of care*. * Figure showing minimum, maximum, median (red),
25th Percentile (green) and 75th percentile (purple)
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patient ranged from 638 to 5,530 Uganda shillings
(UGX) (US$0.25–2.141), which is a ratio of 1:9. For re-
gional referral hospitals, the allocations per patient
ranged from UGX 2,674 to 9,865 (US$1.04–3.82) with a
ratio of 1:4. General hospitals, HC IIIs, and HC IIs had
less intra-level variation in allocations per patient with
ratios of approximately 1:3: UGX 2,367–6,056
(US$0.92–2.34); UGX1,009–2,795 (US$0.39–1.08); and
UGX431–1,367 (US$0.17–0.53), respectively.
Vertical equity
The annual value of the kit allocation for HC IIs was
UGX 7.2 million (US$2,791) and for HC IIIs, it was
UGX 20.7 million (US$8,023). HC IVs and general
hospitals also got uniform EMHS allocations of UGX
43.2 million (US$16,744) and UGX366.4 million
(US$142,015), respectively. The EMHS allocations for
regional referral hospitals were more diversified with
three levels: UGX 747 million (US$289,535), UGX 900
million (US$348,837), and UGX 1.2 billion (US$465,116),
which resulted in a 60 % variation in allocations per pa-
tient. The smallest difference in average EMHS allocations
per patient was 18 % between HC IIIs and HC IVs. The
difference between HC IVs and general hospitals was the
largest, with general hospitals having 115 % more in allo-
cations per patient on average than HC IVs (Table 2). We
also documented considerable overlap of the allocation
per patient between levels (Fig. 2). Most striking was that
over 75 % of HC IV facilities had the same or lower alloca-
tion per patient than the average per patient allocation for
HC IIIs.
Ability to meet needs within the EHMS allocation
HC IIs reported the lowest (63 %) average availability of
vital EMHS on the day of visit and hospitals the highest,
with 88 % for general hospitals and 87 % for regional re-
ferral hospitals. General hospitals had the shortest aver-
age time out-of-stock at 8 %, and HC IVs had the
longest average time out-of-stock (28 %) (Table 3).
Overall, 43 % of all the facilities had optimal stock
levels, while 27 % were understocked and 30 % were
overstocked. Generally, a greater percentage of facilities
that placed their own orders had optimal stock levels,
while lower-level facilities that received kits were pre-
dominantly under- or overstocked (Fig. 3).
Figure 4 shows the robust correlation between annual
stock-out days and per patient allocation for the higher-
level facilities, which was strongest among HC IV facilities.
Options for improved equity
HC IV and general hospitals
The ratios of the highest and lowest allocations per
patient for HC IVs and general hospitals were 1:15
and 1:4, respectively. We simulated allocation per pa-
tient based on the overall 2013/14 funding for HC
IVs (UGX 9.7 billion, US$3.7 million) and general
hospitals (UGX 16.85 billion, US$6.5 million) and es-
timated patient loads. With the simulation, we could
improve horizontal equity by reducing this ratio to
less than two for both levels (Tables 4 and 5). The
simulation also eliminated the overlap in EMHS allo-
cations per patient between the two levels of care,
thereby improving vertical equity.
Table 2 EMHS Allocation per patienta in 2012/13 by level of care










Minimum (UGX) 431 1009 638 2367 2674
Maximum (UGX) 1367 2795 5530 6056 9865
Median (UGX) 922 1521 1328 3700 4041
Mean (UGX) 930 1577 1901 3985 5022
Ratio of means between levels 1.0 1.7 2.0 4.3 5.4
% increase in mean allocation from previous level 70 % 18 % 115 % 26 %
Ratio highest: lowest amount range within level 3.2x 2.8x 8.7x 2.6x 3.7x
a Calculated by annual facility EMHS VOTE 116 allocation divided by annual patient load










hospital (n = 13)
Number of medicines in basket used for measuring availability 6 10 14 14 14
Average % of basket of vital EMHS that were available on day of
the visit, independent of the amount available
63 % 77 % 67 % 88 % 87 %
Average % time out of stock for all the items in basket of vital EMHS
for the specific level of care, measured as % of stock out days/ year (365 days)
21 % 17 % 28 % 8 % 15 %
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HC II
Outpatient visits from over 400 HC IIs that had
complete datasets for January 2012 to December 2012
varied from 1012 visits for Bukuumi HC II to 21,565
visits for Kasonga HC II—a 20-fold difference. Given
that in 2013/14, each HC II was allocated UGX 7.2
million (US$2,791) to procure EMHS, the allocation
per patient range of UGX 334 to 7,115 (US$0.13–
2.76), is even wider than the previous year’s results.
Based on the simulation, a kit with EMHS to treat
priority diseases worth UGX 500,000 (US$194) is sug-
gested, and an HC II would receive between 2 and 31 kits
every year depending on its patient load (Table 6).
Discussion
Ensuring equity in the allocation of EMHS funding in
developing countries is hampered by insufficient funding
and poor data quality. As mentioned, many factors influ-
ence EMHS need, including disease burden, poverty,
and quality of health care, all of which create a complex
situation. At one end of the spectrum is the simple
“one-size-fits-all” allocation, where all facilities get the
same amount, and at the other end, allocation is based
on individual facility requirements. It is against this
background that we explored equity in EMHS funding
allocation and options for improvement. Our sample in-
cluded both primary care and referral facilities and rep-
resented the public health sector’s diversity in terms of
patient load, geographical location, and morbidity
patterns.
Data collection
Collecting data was constrained by lack of structured fi-
nancial data at facility level and data and reporting qual-
ity and completeness. To minimize data quality issues,
we collected financial and patient data from facilities,
from the district health information system, and from
National Medical Stores records. Product availability in-
formation could only be collected from facilities and
depended on how well the facilities were able to manage
medicines and place orders. Only higher-level facilities
could optimize EMHS availability through placing their
Fig. 3 Availability* of vital medicines within each level of care. *
Availability measured as percent of facilities that are over
(>5 months), under (<2 months) or appropriately stocked
(2–5 months)
Fig. 4 Correlation between stock-out for vital medicines per year and allocation/patient by level of care















>60,000 7 130 2,167
40,000–60,000 10 95 2,375 1,583
30,000–39,999 56 61 2,033 1,525
20,000–29,999 94 45 2,250 1,500
<20,000 7 32 1,600
Overall 174 2,375 1,525 1.6
a(Inpatients*3.3)+ outpatients
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own orders because lower-level facilities receive pre-
determined kit supplies. By using inclusion criteria
linked to SPARS scores, we assured a minimal level of
medicines management capacity at the facilities included
in the sample. To ensure uniform and high quality data
collection, experienced medicines management supervi-
sors collected the data and calculated the average
monthly consumption. Patient load and EMHS alloca-
tion financial data correlated well with facility informa-
tion and the national district health information system
and the National Medical Stores.
Allocations per patient
Our study found that EMHS funding allocations to
Uganda’s public sector health facilities do not match the
facilities’ EMHS needs based on the number of patients
that they serve. Patient loads within each level of care
vary from 3-fold to as much as 10-fold; however, every
facility at the same level receives the same allocation.
This means that a sick patient is unlikely to be treated in
the same way in two different facilities at the same level
of care. Our assessment of vertical equity revealed that
referral hospitals’ average EMHS allocation per patient
was about five times higher than the average HC II allo-
cation. However, allocations per patient overlap greatly
across levels of care and often do not reflect service de-
livery expectations. For example, the 18 % difference in
average allocation per patient for HC IVs compared to
HC IIIs is remarkable given the comprehensive services
offered at HC IVs and their greater EMHS needs [5]. Al-
though the National Medical Stores took steps to ad-
dress this anomaly in 2013/14 by increasing the HC IV
allocation by 30 %, from UGX 43.2 million to UGX 56
million (US$16,744–21,705), further work needs to de-
termine the best EMHS allocation per patient based on
the services to be provided at each level and with the
funding available.
Medicine availability
A facility’s ability to respond to patient needs is directly
linked to availability of the medicines required for the
specific level of care, which is a function of the facility’s
funding allocation and their capacity to place EMHS or-
ders and adequately manage their medicines. Our results
found optimal stock levels in hospitals and HC IVs,
which likely reflect the fact that facilities that place their
own EMHS orders can better identify and meet their ac-
tual requirements compared to those facilities that
Table 6 Proposed kit allocations for HCII
Annual outpatient attendance Number of kitsa Value / year (UGX) Allocation/patient (highest for band)
>15,000 31 15,500,000 1033
14000 s 29 14,500,000 1036
13,000 s 27 13,500,000 1038
12,000 s 25 12,500,000 1042
11,000 s 23 11,500,000 1045
10,000 s 21 10,500,000 1000
9,000 s 19 9,500,000 1056
8,000 s 17 8,500,000 1063
7,000 s 15 7,500,000 1071
6,000 s 13 6,500,000 1083
5,000 s 11 5,500,000 1100
4,000 s 9 4,500,000 1125
3,000 s 7 3,500,000 1167
2,000 s 5 2,500,000 1250
1,000 s 3 1,500,000 1500
<1,000 s 2 1,000,000 1000
aAnnual kit value of 1 is UGX 500.000















>100,000 12 490 4,900
80,000–99,999 10 400 5,000 4,000
60,000–79,999 12 350 5,833 4,375
40,000–59,999 7 235 5,875 3,917
<40,000 5 150 3,750
Overall 47 5,875 4,000 1.5
a(Inpatients*3.3)+ outpatients
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depend on predetermined kits. Although public sector
stock-outs can be mitigated by redistributing EMHS,
and national redistribution guidelines do exist, it is an
expensive option that should be avoided in favor of fol-
lowing needs-based allocation principles.
A proposed allocation system based on patient load
The Ministry of Health has previously proposed using
patient load to determine EMHS funding [20, 21]. We il-
lustrate that with a system based on five different patient
load bands for general hospitals, allocations per patient
would range from UGX 4,000 to 5,875 (US$1.55–2.28),
thus reducing the approximately four-fold variation that
currently exists. The HC IV level offers an even bigger
opportunity to improve horizontal equity using a five-
band system. The resulting allocations there, ranging
from UGX 1,525 to UGX 2375 (US$0.59–0.92), would
decrease the ratio to less than two compared to the 15-
fold variation in the 2013/14 allocations. Restricting the
variation between the highest and lowest allocations per
patient would also remove the overlap between levels of
care and enhance vertical equity. Similarly, the 20-fold
variation in patient load at HC IIs has to be addressed
by providing kit quantities accordingly, if allocations are
to be fair and equitable and variations in stock availabil-
ity reduced.
In addition to patient load, other factors influence
EMHS needs in a facility. Given the present level of sys-
tem development and the quality of information available,
it is difficult to allocate EHMS very precisely. Therefore, a
simplified, but not “perfect” allocation system or formula
needs to be put in place initially that would improve
equity, but allow for some variation. The need for an allo-
cation formula as a means to improve allocation equity
has been confirmed in a review study [22].
When limited funding is available for EMHS, as is the
case in Uganda with less than US$1 per capita spent an-
nually, the majority of funds must go toward making the
most vital supplies available at all facilities. Therefore,
the proposed EMHS allocation system minimizes the
variations in per patient allocations within the same level
of care while maximizing the availability of lifesaving
medicines.
Our proposed allocation system has limitations. The
EMHS requirements for the same number of patients in
a poor, disadvantaged area are bound to be different
from those of an urban, affluent area. The risk that the
poor are marginalized in a health allocation system
always exists, but could be considerable in our recom-
mended system because we have not tried to address the
depth of need and disparities in access to care [23, 24].
Other allocation principles have considered additional
variables such as infant mortality rate index, hard-to-
reach area index, and deprivation index. However,
increasing the number of variables also increases the
complexity and data needs, and as Fig. 1 illustrates,
many of these variables are closely related to patient
load. In spite of the limitations, ultimately, using patient
load as a proxy for need in situations where data is lim-
ited offers a simple and practical solution to a complex
issue as well as an incremental improvement over the
current system until better data becomes available.
Additional studies
Studies that address medicines funding allocation and
availability in Uganda or similar settings are rare. A sys-
tematic search of applicable literature revealed two stud-
ies that could shed additional light on the topic [6, 21].
The evidence base for sound decision making on how to
increase access to medicines in Uganda, particularly
given the financial constraints, is shallow and additional
research is needed.
Conclusions
This study presents evidence of inequity in EMHS allo-
cations to public sector health facilities in Uganda as
demonstrated by the wide range of funding allocations
per patient at all levels of care and the corresponding
disparities in medicines availability. We show that in
spite of potential limitations, using patient load as the
basis of EMHS allocations in public health facilities has
the potential to significantly improve equity in health
care service delivery. We also highlight the urgent need
for more research in this area.
Endnote
1Based on an exchange rate of 2,584 UGX per US$1.
Additional file
Additional file 1: The data collection tool is attached in Additional file
1. (DOCX 169 kb)
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